
2021 PTAB Year in Review (RECORDING)
-
You must log in to register
- Non-member - $150
- Member - Free!
Join us as our panel of experts from industry and private practice discusses key PTAB developments from 2021. Important PTAB decisions will be highlighted, as well as impacts on PTAB practice from external sources such as the Supreme Court, Federal Circuit, and Congress. Find out what you need to know about what happened at PTAB last year and what to watch out for in 2022!
This webinar is sponsored by Finnegan, Henderson, Farabow, Garrett & Dunner

Tom Irving
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Tom Irving is a partner with Finnegan. He has more than 40 years of experience in the field of intellectual property law. His practice includes America Invents Act (AIA) post-grant proceedings, due diligence, counseling, patent prosecution, and reissue and reexamination. He counsels clients on a wide range of mainly pharmaceutical matters, including pre-litigation, Orange Book listings of patents covering FDA-approved drugs, infringement issues, enforceability and validity analysis.

Mark Feldstein, Ph.D.
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Mark Feldstein, Ph.D. is a partner at Finnegan. He is a patent and trade secret litigator in U.S. district courts and also serves as lead counsel for clients in post-grant trial proceedings at the USPTO. He also maintains an active patent prosecution practice on behalf of domestic and foreign clients. His practice encompasses issues involving pharmaceuticals, biochemistry, polymers, small molecule chemistry, nanotechnology, optics, and medical and analytic devices. He holds a Ph.D. in chemistry.

Joshua Goldberg
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Joshua Goldberg, leader of Finnegan’s PTAB trials section, focuses on inter partes review (IPR), covered business method (CBM), and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and on ensuing appeals to the U.S. Court of Appeals for the Federal Circuit.

Jessica Marks
Senior Patent Counsel
Unified Patents
Jess Marks prepares and litigates post-grant proceedings before the PTAB for Unified Patents. Prior to joining Unified, Jess practiced at Finnegan, Henderson, Farabow, Garret & Dunner, LLP for over ten years. At Finnegan, Jess litigated post-grant proceedings, district court cases, and International Trade Commission proceedings. Jess is also experienced in licensing negotiations, patent prosecution, due diligence investigations, and opinions on patent infringement, patent validity, and freedom-to-operate. Jess’ cases included electrical, business method, and biological technologies ranging from video surveillance systems, Blu-ray disc players, image processing, artificial intelligence, medical devices, and pharmaceuticals. Jess earned her J.D. from the University of Maryland (now Francis King Carey) School of Law and her M.B.E. and B.A. in Biology from the University of Pennsylvania.

Nichole Valeyko
Patent Attorney
Merck & Co.
Nichole Valeyko is a patent attorney for Merck. Prior to joining Merck in 2019, Nichole worked in private practice for 15 years handling various intellectual property matters, including patent preparation and prosecution, and PTAB proceedings. Nichole has a J.D. from Seton Hall, an M.S. in biotechnology from Johns Hopkins, and a B.S. in biology from Virginia Tech.
Key:




